- $3.10bn
- $3.01bn
- $3.95bn
- 85
- 82
- 37
- 76
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,945 | 2,548 | 2,773 | 3,756 | 3,954 |
Cost of Revenue | |||||
Gross Profit | 326 | 245 | 254 | 368 | 487 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,836 | 2,563 | 2,690 | 3,570 | 3,680 |
Operating Profit | 109 | -15 | 83 | 186 | 274 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 106 | -20 | 81 | 175 | 257 |
Provision for Income Taxes | |||||
Net Income After Taxes | 82 | -48 | 50 | 130 | 505 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 70 | -56 | 41 | 124 | 486 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 70 | -56 | 41 | 124 | 486 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.68 | -0.12 | 1.75 | 4.72 | 17.2 |